What is the recommended induction agent and dosage for pediatric patients, particularly those with a history of respiratory or cardiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Anesthesia Induction: Agent Selection and Dosing

Recommended Induction Agents

For pediatric patients with respiratory or cardiac disease, ketamine (1-2 mg/kg IV) is the first-line induction agent due to its hemodynamic stability through sympathomimetic effects, while sevoflurane is preferred for inhalational induction in stable patients. 1, 2

Intravenous Induction Agents

Ketamine:

  • Dosing: 1-2 mg/kg IV for most situations 1, 2
  • Alternative dosing: 3-4 mg/kg before 18 months of age; 2 mg/kg after 18 months 3, 2
  • Preferred in hemodynamically unstable patients, septic shock, or hypovolemia due to maintenance of blood pressure through sympathomimetic effects 3, 1, 2
  • Particularly valuable in children with cardiac disease where blood pressure maintenance is critical 1

Etomidate:

  • Dosing: 0.2-0.4 mg/kg IV (maximum: 20 mg) 1, 2
  • First-choice agent in children over 2 years old, except in sepsis 3, 2
  • Minimal hemodynamic effects and reduces intracranial pressure, making it useful in head injury 1, 2
  • Should be avoided in septic patients due to adrenal suppression concerns 3

Propofol:

  • Dosing: 2.5-3.5 mg/kg IV for children 3-16 years (ASA I-II) 4
  • Reduced dosing of 1-1.5 mg/kg for ASA III-IV patients, administered as 20 mg every 10 seconds 4
  • Not recommended for hemodynamically unstable patients due to significant hypotensive effects from decreased preload and afterload 1, 4
  • Preferentially used in elective procedures rather than emergency situations 3

Inhalational Induction

Sevoflurane:

  • Preferred inhalational agent for pediatric induction, starting at 7% maximum inspired concentration 5, 6
  • Provides rapid, smooth induction with minimal airway irritation 5, 7, 6
  • Recommended over desflurane in children with upper respiratory tract infections due to less airway reactivity 3
  • More rapid emergence than halothane with better cardiovascular stability during induction 5, 6
  • Maintenance concentration typically 1-4% (approximately 1 MAC = 2.5%) 5, 8

Premedication Requirements

Atropine Administration:

  • Mandatory for children aged 28 days to 8 years, particularly those with septic shock, hypovolemia, or when succinylcholine is used 3, 1, 2
  • Dosing: 0.01-0.02 mg/kg IV (maximum: 0.5 mg) 1, 2
  • Prevents bradycardia from vagal stimulation during laryngoscopy and direct effects of succinylcholine 3
  • Studies demonstrate reduced PICU mortality and decreased arrhythmia incidence when atropine is administered before intubation 3

Neuromuscular Blocking Agents

Succinylcholine:

  • First-line agent for rapid sequence intubation in children with respiratory or cardiovascular compromise 3, 1, 2, 9
  • Age-specific dosing:
    • Neonates <1 month: 1.8 mg/kg IV 1, 2, 9
    • Infants 1 month to 1 year: 2.0 mg/kg IV 1, 2, 9
    • Children 1-10 years: 1.2 mg/kg IV 1, 2, 9
    • Children >10 years: 1.0-1.5 mg/kg IV 1, 2, 9

Rocuronium:

  • Alternative when succinylcholine is contraindicated (hyperkalemia, neuromuscular disease, burn patients) 3, 1, 2, 9
  • Dosing: 0.9-1.2 mg/kg IV 3, 1, 2
  • Higher doses (1.0-1.2 mg/kg) provide intubating conditions similar to succinylcholine at 60 seconds 3
  • Sugammadex must be immediately available when rocuronium is used for potential reversal in "cannot intubate, cannot ventilate" scenarios 3, 1, 2, 9

Special Considerations for Respiratory Disease

Upper Respiratory Tract Infections:

  • Sevoflurane is preferred over desflurane due to decreased airway reactivity 3
  • Consider establishing IV access prior to induction in high-risk patients to allow rapid treatment of complications 3
  • Propofol decreases laryngeal reactivity compared to sevoflurane, while sevoflurane decreases subglottic reactivity compared to propofol 3

Reactive Airway Disease:

  • Avoid desflurane due to increased bronchial reactivity 3
  • Sevoflurane provides bronchodilation and is well-tolerated 3

Special Considerations for Cardiac Disease

Hemodynamic Management:

  • Ketamine is strongly preferred due to maintenance of sympathetic tone and blood pressure 3, 1
  • Propofol causes dose-dependent decreases in preload and afterload, risking decompensation in cardiac patients 4
  • Slow administration is critical: 20 mg every 10 seconds if propofol must be used, avoiding rapid bolus 4
  • Anticipate need for anticholinergic agents as propofol reduces heart rate through decreased sympathetic activity 4

Common Pitfalls and Caveats

Critical Errors to Avoid:

  • Failure to administer atropine in children under 8 years, especially with succinylcholine use, significantly increases risk of severe bradycardia and mortality 3, 1, 2
  • Using succinylcholine in patients with contraindications (hyperkalemia, neuromuscular disease, burns >24 hours old) can cause fatal cardiac arrest 9
  • Rapid bolus administration in hemodynamically unstable or elderly patients causes severe hypotension, apnea, and oxygen desaturation 4
  • Failure to have sugammadex available when using rocuronium leaves no reversal option in failed intubation scenarios 3, 1, 2
  • Using propofol as first-line in unstable patients rather than ketamine risks cardiovascular collapse 1, 4

Pain on Injection:

  • Propofol causes significant pain in pediatric patients (45% incidence) when administered through small hand veins 4
  • Pretreat with lidocaine 1 mL of 1% solution or use antecubital veins to reduce pain to <10% incidence 4
  • Maximum lidocaine addition: 20 mg per 200 mg propofol to maintain emulsion stability 4

Emergence Agitation:

  • Sevoflurane and desflurane are associated with postoperative agitation and delirium 7, 6
  • More rapid emergence with sevoflurane may result in earlier and more intense postoperative pain compared to halothane 6

References

Guideline

Pediatric Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rapid Sequence Intubation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Paediatric anaesthesia and inhalation agents.

Best practice & research. Clinical anaesthesiology, 2005

Research

[Sevoflurane used for induction and maintenance of anaesthesia in children].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2007

Guideline

Pediatric Anesthesia Induction Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.